Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Swiss (SMI) Healthcare Sector Analysis

UpdatedNov 24, 2024
DataAggregated Company Financials
Companies35
  • 7D0.8%
  • 3M-7.3%
  • 1Y10.7%
  • YTD7.8%

Over the last 7 days, the Healthcare industry has dropped 3.0%, driven by Roche Holding declining 0.6%. Over the past 12 months, the industry was up 9.3%. Looking forward, earnings are forecast to grow by 13% annually.

Sector Valuation and Performance

Has the Swiss Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 24 Nov 2024CHF 578.0bCHF 151.8bCHF 24.4b29.8x23.7x3.8x
Tue, 22 Oct 2024CHF 616.2bCHF 148.6bCHF 22.6b31x27.3x4.1x
Thu, 19 Sep 2024CHF 603.6bCHF 147.1bCHF 22.3b32.2x27x4.1x
Sat, 17 Aug 2024CHF 619.1bCHF 148.3bCHF 22.4b32.5x27.7x4.2x
Mon, 15 Jul 2024CHF 595.8bCHF 148.7bCHF 22.7b37.8x26.3x4x
Wed, 12 Jun 2024CHF 567.6bCHF 149.0bCHF 22.7b34.4x25x3.8x
Fri, 10 May 2024CHF 540.6bCHF 146.0bCHF 22.8b32.7x23.7x3.7x
Sun, 07 Apr 2024CHF 543.6bCHF 144.4bCHF 22.3b35.9x24.4x3.8x
Tue, 05 Mar 2024CHF 532.4bCHF 143.3bCHF 22.7b36.7x23.5x3.7x
Thu, 01 Feb 2024CHF 539.2bCHF 152.5bCHF 21.4b33.3x25.2x3.5x
Sat, 30 Dec 2023CHF 522.6bCHF 150.5bCHF 21.7b26.4x24.1x3.5x
Mon, 27 Nov 2023CHF 516.0bCHF 153.6bCHF 22.0b24.9x23.4x3.4x
Wed, 25 Oct 2023CHF 503.8bCHF 153.3bCHF 21.6b25.6x23.3x3.3x
Fri, 22 Sep 2023CHF 535.8bCHF 145.4bCHF 21.2b32.4x25.3x3.7x
Sun, 20 Aug 2023CHF 538.9bCHF 144.0bCHF 21.1b29.2x25.6x3.7x
Tue, 18 Jul 2023CHF 550.1bCHF 144.9bCHF 22.0b35.9x25x3.8x
Thu, 15 Jun 2023CHF 567.2bCHF 147.2bCHF 22.2b34.8x25.5x3.9x
Sat, 13 May 2023CHF 586.5bCHF 147.1bCHF 22.2b35.1x26.4x4x
Mon, 10 Apr 2023CHF 574.6bCHF 147.3bCHF 22.4b33.1x25.6x3.9x
Wed, 08 Mar 2023CHF 532.8bCHF 149.1bCHF 22.6b30.8x23.6x3.6x
Fri, 03 Feb 2023CHF 563.8bCHF 148.7bCHF 24.9b32.4x22.6x3.8x
Sun, 01 Jan 2023CHF 559.7bCHF 148.5bCHF 38.0b29.7x14.7x3.8x
Tue, 29 Nov 2022CHF 580.9bCHF 149.8bCHF 38.5b33.6x15.1x3.9x
Thu, 27 Oct 2022CHF 583.6bCHF 151.9bCHF 39.3b28.3x14.9x3.8x
Sat, 24 Sep 2022CHF 544.0bCHF 152.1bCHF 40.3b27x13.5x3.6x
Mon, 22 Aug 2022CHF 594.6bCHF 150.4bCHF 39.8b33.3x15x4x
Wed, 20 Jul 2022CHF 608.3bCHF 149.7bCHF 40.7b33.2x14.9x4.1x
Fri, 17 Jun 2022CHF 559.5bCHF 149.1bCHF 40.6b29.1x13.8x3.8x
Sun, 15 May 2022CHF 607.7bCHF 150.9bCHF 41.3b32.4x14.7x4x
Tue, 12 Apr 2022CHF 699.0bCHF 145.8bCHF 39.2b39x17.8x4.8x
Thu, 10 Mar 2022CHF 624.1bCHF 145.0bCHF 39.0b32.5x16x4.3x
Sat, 05 Feb 2022CHF 635.2bCHF 144.4bCHF 38.4b44.8x16.5x4.4x
Mon, 03 Jan 2022CHF 695.7bCHF 138.7bCHF 25.1b48.6x27.7x5x
Wed, 01 Dec 2021CHF 669.5bCHF 138.9bCHF 25.2b44.8x26.6x4.8x
Price to Earnings Ratio

26.6x


Total Market Cap: CHF 669.5bTotal Earnings: CHF 25.2bTotal Revenue: CHF 138.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Healthcare Sector Price to Earnings3Y Average 21.8x202220232024
Current Industry PE
  • Investors are relatively neutral on the Swiss Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 21.9x.
  • The industry is trading close to its 3-year average PS ratio of 3.9x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 2.9% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare sector?

CH Market0.61%
Healthcare0.83%
Healthcare Services1.99%
Life Sciences1.34%
Pharma0.79%
Medical Equipment0.66%
Biotech-1.37%
Healthtech-3.53%
Industry PE
  • Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio of 47.3x.
    • Analysts are expecting annual earnings growth of 22.4%, which is higher than its past year's earnings growth of 4.3% per year.
Forecasted Growth
  • Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 22% over the next 5 years.
  • This is better than its past earnings growth rate of 4.3% per year.
  • In contrast, the Healthcare Services industry is expected to see its earnings grow by 5.3% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
NOVN NovartisCHF 93.682.1%
+CHF 3.9b		7.9%PE17.8x
ALC AlconCHF 76.682.1%
+CHF 771.6m		18.6%PE36.5x
LONN Lonza GroupCHF 521.401.8%
+CHF 650.0m		48.8%PE65.7x
GALD Galderma GroupCHF 87.652.7%
+CHF 548.8m		n/aPS5.4x
SDZ Sandoz GroupCHF 40.601.1%
+CHF 188.6m		53.8%PS2x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

NOVN

CHF 93.68

Novartis

7D

2.1%

1Y

7.9%

MOVE

CHF 110.80

Medacta Group

7D

-1.9%

1Y

-5.9%

The Price Is Right For Medacta Group SA (VTX:MOVE)

Nov 22
The Price Is Right For Medacta Group SA (VTX:MOVE)

SOON

CHF 312.10

Sonova Holding

7D

-1.0%

1Y

24.7%

A Look At The Intrinsic Value Of Sonova Holding AG (VTX:SOON)

Nov 22
A Look At The Intrinsic Value Of Sonova Holding AG (VTX:SOON)

YPSN

CHF 357.00

Ypsomed Holding

7D

-1.9%

1Y

21.6%

GALD

CHF 87.65

Galderma Group

7D

2.7%

1Y

n/a

ALC

CHF 76.68

Alcon

7D

2.1%

1Y

18.6%

GALE

CHF 77.15

Galenica

7D

2.9%

1Y

7.8%

Galenica AG's (VTX:GALE) Popularity With Investors Is Under Threat From Overpricing

Nov 12
Galenica AG's (VTX:GALE) Popularity With Investors Is Under Threat From Overpricing

PPGN

CHF 27.95

PolyPeptide Group

7D

-3.0%

1Y

48.9%

PolyPeptide Group AG's (VTX:PPGN) Intrinsic Value Is Potentially 19% Below Its Share Price

Nov 11
PolyPeptide Group AG's (VTX:PPGN) Intrinsic Value Is Potentially 19% Below Its Share Price

BANB

CHF 67.50

Bachem Holding

7D

-2.0%

1Y

-4.3%

Here's Why We Think Bachem Holding (VTX:BANB) Is Well Worth Watching

Nov 10
Here's Why We Think Bachem Holding (VTX:BANB) Is Well Worth Watching

SFZN

CHF 1,114.00

Siegfried Holding

7D

3.7%

1Y

40.2%

Siegfried Holding AG's (VTX:SFZN) Price In Tune With Earnings

Nov 09
Siegfried Holding AG's (VTX:SFZN) Price In Tune With Earnings

LONN

CHF 521.40

Lonza Group

7D

1.8%

1Y

48.8%

Is Lonza Group (VTX:LONN) Using Too Much Debt?

Nov 08
Is Lonza Group (VTX:LONN) Using Too Much Debt?

STMN

CHF 111.50

Straumann Holding

7D

0.6%

1Y

-8.7%

ROG

CHF 254.30

Roche Holding

7D

-0.6%

1Y

6.5%

DESN

CHF 237.50

Dottikon ES Holding

7D

-1.0%

1Y

6.7%

What You Can Learn From Dottikon ES Holding AG's (VTX:DESN) P/E

Oct 19
What You Can Learn From Dottikon ES Holding AG's (VTX:DESN) P/E

SDZ

CHF 40.60

Sandoz Group

7D

1.1%

1Y

53.8%

MEDX

CHF 8.65

medmix

7D

-7.5%

1Y

-53.6%

medmix AG (VTX:MEDX) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough

Aug 11
medmix AG (VTX:MEDX) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough